Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PAIN MANAGEMENT CENTERS OF AMERICA, PSC

NPI: 1992271811 · EVANSVILLE, IN 47714 · Psychiatry Physician · NPI assigned 10/18/2018

$11.24M
Total Medicaid Paid
358,715
Total Claims
286,672
Beneficiaries
67
Codes Billed
2019-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialSANAPATI, MAHENDRA (PRESIDENTR)
NPI Enumeration Date10/18/2018

Related Entities

Other providers sharing the same authorized official: SANAPATI, MAHENDRA

ProviderCityStateTotal Paid
ADVANCED PAIN CARE CLINIC PSC EVANSVILLE IN $1.18M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2019 59,146 $1.53M
2020 67,104 $1.90M
2021 65,528 $2.14M
2022 66,332 $2.08M
2023 61,372 $2.04M
2024 39,233 $1.54M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 119,819 93,627 $2.80M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 72,853 61,679 $2.36M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 62,454 50,331 $2.14M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 41,908 35,587 $2.08M
62323 5,225 4,260 $320K
64483 2,740 2,288 $199K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 2,462 1,994 $167K
62321 2,271 1,888 $136K
99442 5,828 4,392 $97K
64490 1,222 990 $79K
62370 3,338 2,042 $76K
64633 474 402 $73K
64493 1,076 814 $60K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 1,529 1,220 $58K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 3,479 2,838 $58K
64484 1,105 918 $57K
27096 435 324 $55K
62369 2,288 1,537 $48K
64491 1,306 988 $43K
99215 Prolong outpt/office vis 567 405 $34K
64494 1,102 773 $32K
64420 1,285 822 $28K
64421 2,049 1,061 $28K
64634 560 385 $26K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 461 400 $24K
64635 108 89 $19K
76881 391 247 $19K
95886 221 172 $15K
95913 77 59 $9K
77002 771 611 $9K
90834 Psychotherapy, 45 minutes with patient 440 221 $7K
99205 Prolong outpt/office vis 81 58 $7K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 2,140 1,745 $7K
64636 128 89 $7K
J3490 Unclassified drugs 2,290 648 $7K
95911 82 60 $6K
20610 203 163 $5K
00670 76 51 $5K
99443 212 155 $5K
20611 74 54 $4K
76942 87 68 $3K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 114 88 $3K
90792 Psychiatric diagnostic evaluation with medical services 66 53 $3K
99406 788 552 $2K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 310 243 $2K
J1040 Injection, methylprednisolone acetate, 80 mg 314 240 $2K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 255 218 $2K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 255 200 $2K
20552 67 54 $2K
99072 3,280 2,658 $2K
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion 147 143 $2K
99441 51 34 $926.78
01940 28 25 $780.50
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 1,868 1,581 $389.37
98967 170 109 $340.77
J1885 Injection, ketorolac tromethamine, per 15 mg 462 351 $183.27
77003 69 63 $174.85
J1100 Injection, dexamethasone sodium phosphate, 1 mg 122 99 $111.27
80305 158 112 $69.88
62368 15 12 $40.46
J1030 Injection, methylprednisolone acetate, 40 mg 19 12 $2.02
G8730 Pain assessment documented as positive using a standardized tool and a follow-up plan is documented 1,425 950 $0.00
G9562 Patients who had a follow-up evaluation conducted at least every three months during opioid therapy 1,204 813 $0.00
G9584 Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy 1,242 830 $0.00
888888 77 77 $0.00
A4220 Refill kit for implantable infusion pump 77 60 $0.00
G9578 Documentation of signed opioid treatment agreement at least once during opioid therapy 915 640 $0.00